World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
127
Citations
83392
World Ranking
2778
National Ranking
1549

Arie Perry publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Arie Perry sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 637 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Arie Perry D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Arie Perry sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 127 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Arie Perry is affiliated with the University of California, San Francisco in the United States. Their research spans several fields within medicine, with a particular focus on genetics, neurology, epidemiology, molecular biology, and pulmonary and respiratory medicine.

The main topics of Perry's work cover a diverse range of areas including:

  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Neurofibromatosis and Schwannoma Cases
  • Neuroblastoma Research and Treatments
  • Pituitary Gland Disorders and Treatments
  • Chromatin Remodeling and Cancer
  • Sarcoma Diagnosis and Treatment

Major publication venues for Perry include:

  • Neuro-Oncology
  • Acta Neuropathologica
  • Brain Pathology
  • Endocrine Pathology
  • Neuro-Oncology Advances

Some of Perry's recent papers are:

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary (2021, Neuro-Oncology)
  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading (2020, Brain Pathology)
  • Overview of the 2022 WHO Classification of Pituitary Tumors (2022, Endocrine Pathology)
  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020, Acta Neuropathologica)
  • Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities (2022, Nature Genetics)

Frequent coauthors collaborating with Perry include:

  • David R. Raleigh
  • David A. Solomon
  • Melike Pekmezci
  • Mitchel S. Berger
  • Calixto-Hope G. Lucas

Best Publications

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

    David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

    David N Louis;Arie Perry;Pieter Wesseling;Daniel J Brat

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

    Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh

  • Primary brain tumours in adults.

    Sarah Lapointe;Arie Perry;Nicholas A Butowski

  • Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas

    Justin S. Smith;Arie Perry;Thomas J. Borell;Hyun K. Lee

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

    Daniel J. Brat;Kenneth Aldape;Howard Colman;Eric C. Holland

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • Meningioma grading: an analysis of histologic parameters.

    Arie Perry;Scott L. Stafford;Bernd W. Scheithauer;Vera J. Suman

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

    Arie Perry;Bernd W. Scheithauer;Scott L. Stafford;Christine M. Lohse

  • Pathology of Peripheral Nerve Sheath Tumors: Diagnostic Overview and Update on Selected Diagnostic Problems

    Fausto J. Rodriguez;Andrew L. Folpe;Caterina Giannini;Arie Perry

  • Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

    David W. Ellison;James Dalton;Mehmet Kocak;Sarah Leigh Nicholson

  • Histological classification and molecular genetics of meningiomas.

    Markus J Riemenschneider;Arie Perry;Guido Reifenberger

  • Notch1 and notch2 have opposite effects on embryonal brain tumor growth.

    Xing Fan;Irina Mikolaenko;Ihab Elhassan;Xing Zhi Ni

  • Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    Nicholas Butowski;Howard Colman;John F. De Groot;Antonio M. Omuro

  • Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging.

    Karen M. Gauvain;Robert C. McKinstry;Pratik Mukherjee;Arie Perry

  • Pathological classification and molecular genetics of meningiomas

    Christian Mawrin;Arie Perry

  • Glioblastoma: Morphologic and molecular genetic diversity

    C. Ryan Miller;Arie Perry

Frequent Co-Authors

David A. Solomon
David A. Solomon University of California, San Francisco
Joanna J. Phillips
Joanna J. Phillips University of California, San Francisco
David H. Gutmann
David H. Gutmann Washington University in St. Louis
Tarik Tihan
Tarik Tihan University of California, San Francisco
Andreas von Deimling
Andreas von Deimling Heidelberg University
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Mitchel S. Berger
Mitchel S. Berger University of California, San Francisco
Daniel J. Brat
Daniel J. Brat Northwestern University
Andrey Korshunov
Andrey Korshunov German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open doors to a wide range of related fields, many of which can be accessed through online degrees. For those interested in mental health, online nursing programs offer flexible and accelerated paths, such as the shortest post master's pmhnp online programs, allowing you to specialize as a psychiatric nurse practitioner more quickly.

If you’re leaning toward the business side of healthcare, pursuing an online healthcare administration degree can prepare you for leadership and management roles in hospitals, clinics, or insurance companies. Cost is an important factor—many students look for the cheapest master’s in healthcare administration to minimize debt and maximize career returns.

Advanced practice roles, such as nurse practitioners and nurse leaders, also benefit from flexible online programs. For those seeking terminal nursing degrees, the cheapest dnp programs let you gain clinical expertise and leadership skills fully online, often while continuing to work.

These online pathways support a diverse range of careers in healthcare, offering flexible learning and practical advancement for future healthcare leaders, managers, and practitioners.

Best Scientists Citing Arie Perry

Trending Scientists

Recently Published Articles